Cargando…
Novel therapeutic strategies in the treatment of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer that is defined by negative estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status. Treating patients with TNBC remains clinically challenging, as patients are not...
Autores principales: | Oualla, Karima, El-Zawahry, Heba M., Arun, Banu, Reuben, James M., Woodward, Wendy A., Gamal El-Din, Heba, Lim, Bora, Mellas, Nawfel, Ueno, Naoto T., Fouad, Tamer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502951/ https://www.ncbi.nlm.nih.gov/pubmed/28717401 http://dx.doi.org/10.1177/1758834017711380 |
Ejemplares similares
-
Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives
por: Oualla, Karima, et al.
Publicado: (2020) -
Giant metastasis of the thenar eminence revealing ovarian rhabdomyosarcoma
por: Oualla, Karima, et al.
Publicado: (2020) -
Awareness and practices of Arab oncologists towards oncofertility in young women with cancer
por: Kassem, Loay, et al.
Publicado: (2022) -
How Is Morocco Reacting to COVID-19 Crisis in Anticancer
Centers?
por: Oualla, Karima, et al.
Publicado: (2020) -
Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 as a Biomarker
por: Oualla, Karima, et al.
Publicado: (2021)